GLP-1 medications reduce appetite significantly, and when combined with travel convenience foods (which are typically high carb, low protein), muscle loss can accelerate
Dehydration leading to acute kidney injury can occur with severe gastrointestinal side effects
Patients should report persistent stool changes to their GP, particularly if accompanied by abdominal pain, as GLP-1 therapy carries rare risks of pancreatitis and gallbladder disease
GLP-1 is Glucagon-Like Peptide-1 (and yes, there is a 2)
It is used in people with BMI 30 kg/m 2 or 27 kg/m 2 with co-morbidity (e.g., hypertension, diabetes, dyslipidaemia) [9]
Open any type for the detail or search your exact drug in the checker above